Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemophase with Mitomycin C in Non-Muscle Invasive Bladder Cancer
NCT00318643Phase 2Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Mar 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mitomycin c in bladder cancer, sponsored by Halozyme Therapeutics, Inc.. Started Mar 2006; status: completed.
02
Drugs
mitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00318643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318643.